Compare AMLX & RDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMLX | RDW |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.4B |
| IPO Year | 2021 | 2020 |
| Metric | AMLX | RDW |
|---|---|---|
| Price | $27.71 | $10.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $42.36 | $14.69 |
| AVG Volume (30 Days) | 1.2M | ★ 10.8M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.46 | 2.98 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $380,786,000.00 | $335,381,000.00 |
| Revenue This Year | N/A | $41.71 |
| Revenue Next Year | N/A | $18.65 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1612.94 | 10.29 |
| 52 Week Low | $10.83 | $4.87 |
| 52 Week High | $41.14 | $26.64 |
| Indicator | AMLX | RDW |
|---|---|---|
| Relative Strength Index (RSI) | 36.58 | 46.59 |
| Support Level | $12.97 | $9.99 |
| Resistance Level | $34.35 | $11.96 |
| Average True Range (ATR) | 1.39 | 0.61 |
| MACD | -0.74 | -0.06 |
| Stochastic Oscillator | 9.33 | 28.42 |
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
Redwire Corp is an integrated space and defense technology company focused on technologies including aerospace infrastructure, autonomous systems and multi-domain operations, leveraging digital engineering and artificial intelligence automation. The Company develops and provides mission critical solutions based on space and defense technology platform offerings for government, commercial and civil customers through both short- and long-duration projects. These include technologies and production capability for next-generation spacecraft, large space infrastructure, microgravity capabilities, combat autonomous systems, optical sensors and radio frequency payloads that provide intelligence, surveillance, and reconnaissance capabilities for U.S. and allied nations across multiple domains.